PathAI Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 250

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 24

PathAI General Information

Description

Developer of an artificial intelligence-powered research platform intended to improve the accuracy and efficiency of cancer diagnosis and treatment. The company's platform applies machine and deep learning techniques to massive aggregated sets in order to detect cancerous cells separately, enabling pathologists to diagnose cancer patients rapidly and accurately.

Contact Information

Website
www.pathai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1325 Boylston Street
  • Suite 10000
  • Boston, MA 02215
  • United States
+1 (617)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Artificial Intelligence & Machine Learning, TMT, HealthTech
Corporate Office
  • 1325 Boylston Street
  • Suite 10000
  • Boston, MA 02215
  • United States
+1 (617)

PathAI Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PathAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Mezzanine 23-Dec-2022 Completed Generating Revenue
6. Debt - General 01-Jan-2022 Completed Generating Revenue
5. Later Stage VC (Series C) 18-May-2021 Completed Generating Revenue
4. Early Stage VC (Series B) 04-Nov-2019 Completed Generating Revenue
3. Early Stage VC 23-Jul-2019 Completed Generating Revenue
2. Accelerator/Incubator 01-May-2018 $15M Completed Generating Revenue
1. Early Stage VC (Series A) 31-Oct-2017 $15M $15M Completed Startup
To view PathAI’s complete valuation and funding history, request access »

PathAI Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A4
Series A3
Series A2
Series A1 2,168,963 $0.000100 6% $1.76 $1.76 1x $1.76 6.3%
Series A 3,449,295 $0.000100 6% $3.25 $3.25 1x $3.25 10.03%
To view PathAI’s complete cap table history, request access »

PathAI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-powered research platform intended to improve the accuracy and efficiency of can
Discovery Tools (Healthcare)
Boston, MA
250 As of 2023

Paris, France
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PathAI Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Keen Eye Formerly VC-backed Paris, France
PredxBio Venture Capital-Backed Pittsburgh, PA
Caris Life Sciences Private Equity-Backed Irving, TX
Aitia Venture Capital-Backed Somerville, MA
Paige Venture Capital-Backed New York, NY
You’re viewing 5 of 11 competitors. Get the full list »

PathAI Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

PathAI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240153616-A1 Systems and methods for deep learning model annotation using specialized imaging modalities Pending 03-Nov-2022
US-20230326022-A1 Machine learning identification, classification, and quantification of tertiary lymphoid structures Pending 08-Apr-2022
US-20220375606-A1 Systems and methods for machine learning (ml) model diagnostic assessments based on digital pathology data Pending 18-May-2021
EP-4341964-A1 Systems and methods for machine learning (ml) model diagnostic assessments based on digital pathology data Pending 18-May-2021
US-20220245802-A1 Systems and methods for classifying biomedical image data using a graph neural network Pending 01-Feb-2021 G06T7/0012
To view PathAI’s complete patent history, request access »

PathAI Executive Team (19)

Name Title Board Seat
Andrew Beck Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Matt Grow President and Chief Business Officer of Biopharma
Tiffany Freitas Chief Operating Officer, Co-Chief Financial Officer, and Chief Business Officer
Brandon Eldredge Co-Chief Financial Officer
Elizabeth Storti Chief People Officer
You’re viewing 5 of 19 executive team members. Get the full list »

PathAI Board Members (10)

Name Representing Role Since
Andrew Beck Ph.D PathAI Co-Founder, Chief Executive Officer, President & Board Member
Jeffrey Leiden Ph.D Self Chairman
Stanley Lapidus Self Board Member
You’re viewing 3 of 10 board members. Get the full list »

PathAI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PathAI Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hercules Capital Lender/Debt Provider Minority
Ad Super Corporation Minority
Biospring Partners Growth/Expansion Minority
Camford Capital Venture Capital Minority
D1 Capital Partners Hedge Fund Minority
You’re viewing 5 of 24 investors. Get the full list »

PathAI Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Poplar Healthcare 26-Jul-2021 Laboratory Services (Healthcare)
To view PathAI’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

PathAI FAQs

  • When was PathAI founded?

    PathAI was founded in 2016.

  • Who is the founder of PathAI?

    Andrew Beck Ph.D and Aditya Khosla Ph.D are the founders of PathAI.

  • Who is the CEO of PathAI?

    Andrew Beck Ph.D is the CEO of PathAI.

  • Where is PathAI headquartered?

    PathAI is headquartered in Boston, MA.

  • What is the size of PathAI?

    PathAI has 250 total employees.

  • What industry is PathAI in?

    PathAI’s primary industry is Discovery Tools (Healthcare).

  • Is PathAI a private or public company?

    PathAI is a Private company.

  • What is PathAI’s current revenue?

    The current revenue for PathAI is .

  • How much funding has PathAI raised over time?

    PathAI has raised $395M.

  • Who are PathAI’s investors?

    Hercules Capital, Ad Super, Biospring Partners, Camford Capital, and D1 Capital Partners are 5 of 24 investors who have invested in PathAI.

  • Who are PathAI’s competitors?

    Keen Eye, PredxBio, Caris Life Sciences, Aitia, and Paige are some of the 11 competitors of PathAI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »